Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro

Oncology Letters
|June 22, 2026
PubMed
Summary

This study corrects a previously published article's DOI. The correction ensures accurate citation and retrieval of scientific research on the topic.